John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Rexford Industrial Realty
REXR
$8.3B
| $9.2M | 0.03% |
293,062
+284,241
| +3,222% | +$8.69M |
|
702
Pilgrim's Pride
PPC
$7.68B
| $9.2M | 0.03% |
+456,950
| New | +$9.82M |
|
703
Murphy USA
MUSA
$10.5B
| $9.19M | 0.03% |
123,763
+110,947
| +866% | +$7.66M |
|
704
Genpact
G
$6.24B
| $9.18M | 0.03% |
317,206
+183,382
| +137% | +$5.67M |
|
|
MRSH
705
Marsh
MRSH
$91.6B
| $9.16M | 0.03% |
111,729
-115,014
| -51% | -$9.39M |
|
706
Algonquin Power & Utilities
AQN
$4.39B
| $9.15M | 0.03% |
947,336
-691,291
| -42% | -$6.75M |
|
707
PUT
SLB Ltd
SLB
$79.9B
| $9.14M | 0.03% |
136,300
-241,000
| -64% | -$16.5M |
|
708
Loews
L
$22.5B
| $9.1M | 0.03% |
188,577
+164,670
| +689% | +$8.28M |
|
709
Dick's Sporting Goods
DKS
$16.4B
| $9.09M | 0.03% |
257,902
-1,466,196
| -85% | -$49.8M |
|
710
Strategy Inc
MSTR
$47.4B
| $9.08M | 0.03% |
710,900
-50,690
| -7% | -$660K |
|
711
GSK
GSK
$105B
| $9.06M | 0.03% |
179,735
-518,255
| -74% | -$26.1M |
|
712
CALL
Verizon
VZ
$205B
| $9.04M | 0.03% |
179,700
-669,900
| -79% | -$32.4M |
|
713
Haemonetics
HAE
$4.95B
| $9.03M | 0.03% |
100,701
+92,159
| +1,079% | +$7.78M |
|
|
AVB
714
DELISTED
AvalonBay Communities
AVB
| $9.03M | 0.03% |
52,515
+38,126
| +265% | +$6.3M |
|
715
CALL
Netflix
NFLX
$331B
| $9M | 0.03% |
230,000
+30,000
| +15% | +$1.02M |
|
716
PUT
Lowe's Companies
LOW
$121B
| $8.96M | 0.03% |
93,800
+85,800
| +1,073% | +$7.77M |
|
717
Dr. Reddy's Laboratories
RDY
$10.1B
| $8.84M | 0.03% |
+1,372,810
| New | +$8.66M |
|
718
PUT
Eli Lilly
LLY
$1.12T
| $8.84M | 0.03% |
103,600
+56,100
| +118% | +$4.61M |
|
|
SJR
719
DELISTED
Shaw Communications Inc.
SJR
| $8.84M | 0.03% |
434,101
-679,814
| -61% | -$13.9M |
|
720
PUT
PNC Financial Services
PNC
$97B
| $8.78M | 0.03% |
65,000
+19,600
| +43% | +$2.86M |
|
721
PUT
Digital Realty Trust
DLR
$70.5B
| $8.76M | 0.03% |
78,500
+4,100
| +6% | +$435K |
|
722
ICU Medical
ICUI
$4.57B
| $8.74M | 0.03% |
29,769
+26,556
| +827% | +$7.26M |
|
|
723
PUT
Verizon
VZ
$205B
| $8.72M | 0.03% |
173,300
-762,700
| -81% | -$36.9M |
|
|
K
724
PUT
DELISTED
Kellanova
K
| $8.71M | 0.03% |
132,699
+129,184
| +3,675% | +$7.68M |
|
725
PUT
Newell Brands
NWL
$2.59B
| $8.64M | 0.03% |
335,200
+291,200
| +662% | +$7.58M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.